PRELUDE CAPITAL MANAGEMENT, LLC - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 129 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$50,000
+2400.0%
29,598
+1245.4%
0.00%
Q3 2020$2,000
+100.0%
2,2000.0%0.00%
Q2 2020$1,000
-90.0%
2,200
+82.9%
0.00%
-100.0%
Q2 2014$10,0001,2030.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 291,500$137,0000.14%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$441,0000.14%
CVA Family Office, LLC 1,137,920$535,0000.13%
Cypress Capital Management LLC (WY) 179,525$84,0000.10%
Willis Investment Counsel 2,075,840$976,0000.05%
NTB Financial Corp 146,100$69,0000.05%
SRS Capital Advisors, Inc. 629,172$296,0000.04%
Helen Stephens Group, LLC 117,222$55,0000.04%
COURIER CAPITAL LLC 464,356$218,0000.02%
Western Wealth Management, LLC 946,800$444,0000.02%
View complete list of AMPIO PHARMACEUTICALS INC shareholders